LGALS1 and cancer: Goud et al. synthesized 1-benzyl-benzimidazole derivatives as potential galectin-1 targeted anticancer agents and evaluated their activity against MDA-MB-231, A549, MCF-7, DU-145, HT29, and HCT116 cancer cell lines [162].